Abstract
Matrix metalloproteinases (MMPs) are known to participate in cancer invasion and metastasis. Copious research on MMPs and their inhibitors has promoted the understanding of the mechanisms of cancer invasion and metastasis as well as the development of effective drugs for cancer treatment. This review discusses the classification of MMPs and tissue inhibitors of metalloproteinases (TIMPs) in relation to tumor growth and invasion mechanisms via signal transduction, followed by the possibilities for cancer treatment. The review focuses especially on the development of anti-cancer agents in the field of MMP science.
Keywords: Matrix metalloproteinase (MMP), A disintegrin and metalloproteinase (ADAM), A disintegrin and metalloproteinase with thrombospondin motif (ADAMTS), Tissue inhibitor of metalloproteinases (TIMP), Cancer invasion, Cancer metastasis, Cancer treatment, Anti-cancer agents, cancer cellinvasion, Peptidases.
Anti-Cancer Agents in Medicinal Chemistry
Title:Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream
Volume: 12 Issue: 7
Author(s): Isao Okazaki and Kazuki Nabeshima
Affiliation:
Keywords: Matrix metalloproteinase (MMP), A disintegrin and metalloproteinase (ADAM), A disintegrin and metalloproteinase with thrombospondin motif (ADAMTS), Tissue inhibitor of metalloproteinases (TIMP), Cancer invasion, Cancer metastasis, Cancer treatment, Anti-cancer agents, cancer cellinvasion, Peptidases.
Abstract: Matrix metalloproteinases (MMPs) are known to participate in cancer invasion and metastasis. Copious research on MMPs and their inhibitors has promoted the understanding of the mechanisms of cancer invasion and metastasis as well as the development of effective drugs for cancer treatment. This review discusses the classification of MMPs and tissue inhibitors of metalloproteinases (TIMPs) in relation to tumor growth and invasion mechanisms via signal transduction, followed by the possibilities for cancer treatment. The review focuses especially on the development of anti-cancer agents in the field of MMP science.
Export Options
About this article
Cite this article as:
Okazaki Isao and Nabeshima Kazuki, Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream, Anti-Cancer Agents in Medicinal Chemistry 2012; 12 (7) . https://dx.doi.org/10.2174/187152012802650200
DOI https://dx.doi.org/10.2174/187152012802650200 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Melatonin, A Natural Programmed Cell Death Inducer in Cancer
Current Medicinal Chemistry Biological Evaluation of 3-Acyl-2-Arylamino-1,4-Naphthoquinones as Inhibitors of Hsp90 Chaperoning Function
Current Topics in Medicinal Chemistry MicroRNAs: A Novel Non-Invasive Biomarker for Patients with Urological Malignancies
Current Pharmaceutical Biotechnology Bladder Injury During Cesarean Delivery
Current Women`s Health Reviews The Application of Photofrin II® as a Sensitizing Agent for Ionizing Radiation-A New Approach in Tumor Therapy?
Current Medicinal Chemistry Targeting the Immune System in Cancer
Current Pharmaceutical Biotechnology Lipophilicity and Other Parameters Affecting Brain Penetration
Current Medicinal Chemistry - Central Nervous System Agents Reducing the Burden of Diabetes Treatment: A Review of Low-cost Oral Hypoglycemic Medications
Current Diabetes Reviews A Review of Molecular Predictors of Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer
Mini-Reviews in Medicinal Chemistry Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer
Current Drug Targets Cancer Stem Cells and their Management in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Gene Expression Abnormalities in Thymoma
Current Pharmacogenomics Gold and Silver Nanoparticles for Applications in Theranostics
Current Topics in Medicinal Chemistry DLEU2: A Meaningful Long Noncoding RNA in Oncogenesis
Current Pharmaceutical Design Subject Index to Volume 5
Current Drug Metabolism How is Gene Transfection Able to Improve Current Chemotherapy? The Role of Combined Therapy in Cancer Treatment
Current Medicinal Chemistry Endocannabinoid System in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Renal and Hepatic Kinetics of Tc-99m-labelled Hexakis-methoxy-isobutyl Isonitrile
Drug Metabolism Letters Targeting p73 - a Potential Approach in Cancer Treatment
Current Pharmaceutical Design Targeting Heat Shock Protein 90 for Malaria
Mini-Reviews in Medicinal Chemistry